Average Co-Inventor Count = 5.85
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (15 from 2,405 patents)
2. Merck + Co., Inc. (4 from 4,770 patents)
3. Sloan-Kettering Institute for Cancer Research (4 from 512 patents)
4. Scynexis, Inc. (1 from 18 patents)
5. Mochida Paraceuticals Co., Ltd. (1 from 1 patent)
6. Seynix, Inc. (1 from 1 patent)
7. Seynexis, Inc. (1 from 1 patent)
8. Mochida Pharmaceutical Co., Ltd. (229 patents)
9. Msd R&d Co., Ltd. (0 patent)
23 patents:
1. 12247031 - Cyclobutyl pyrazolopyrimidine PDE9 inhibitors
2. 11028092 - Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
3. 10934294 - Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
4. 10556900 - TrkA kinase inhibitors, compositions and methods thereof
5. 10472345 - Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents
6. 10351558 - Factor IXa inhibitors
7. 10189819 - Factor IXa inhibitors
8. 10144741 - Nargenicin compounds and uses thereof as antibacterial agents
9. 9944654 - Nargenicin compounds and uses thereof as antibacterial agents
10. 9815846 - TrkA kinase inhibitors, compositions and methods thereof
11. 8722727 - Antifungal agents
12. 8481575 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof
13. 8188085 - Antifungal agents
14. 7923568 - Estrogen receptor modulators
15. 7863465 - Antifungal agents